Spots Global Cancer Trial Database for Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies
Official Title: A Phase 1, Open-Label, Multicentre, Non-Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD4573, a Potent and Selective CDK9 Inhibitor, in Subjects With Relapsed or Refractory Haematological Malignancies
Study ID: NCT03263637
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary antitumor activity of AZD4573 in subjects with relapsed or refractory haematological malignancies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Aachen, , Germany
Research Site, Bonn, , Germany
Research Site, Göttingen, , Germany
Research Site, Heidelberg, , Germany
Research Site, Ulm, , Germany
Research Site, Amsterdam, , Netherlands
Research Site, Nieuwegein, , Netherlands
Research Site, Cardiff, , United Kingdom
Research Site, Manchester, , United Kingdom
Research Site, Plymouth, , United Kingdom
Research Site, Southampton, , United Kingdom
Research Site, Sutton, , United Kingdom
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
